NAD⁺ precursorEmerging

NMN (Nicotinamide Mononucleotide)

Direct NAD+ precursor. Early-phase clinical evidence shows raised blood NAD+ levels after oral dosing.

Also known as: nmn-500, nicotinamid-mononukleotid

How it works

NMN (nicotinamide mononucleotide) is a direct precursor of NAD+, just one enzymatic step away. Because NAD+ falls with age and is central to energy, DNA repair and sirtuins, NMN is meant to offset that decline. The NAD+ rise is documented, but clinical longevity effects in humans remain open; the hype outpaces the evidence.

Goals
EnergyCognitionLongevity (broad)
Timing
Morning
Price tier
Premium

Dosage

250–500 mg/day, morning.

Considerations

Quality varies. Look for third-party testing and ≥99% purity.

VeganNot during pregnancy
Form
CapsuleSublingual

Scientific detail

Mechanisms
NAD metabolismSirtuin activationMitochondrial biogenesis
Hallmarks of aging
Mitochondrial dysfunctionDeregulated nutrient sensing
Evidence base

Studies on NMN (Nicotinamide Mononucleotide)

1,452 studies total · Open on PubMed

View all studies
My pick

Currently in my stack:

NMNH Ultra Strength 1000 mg — NAD+ Booster, 120 Kapseln
NMNH
NMNH Ultra Strength 1000 mg — NAD+ Booster, 120 Kapseln
1 capsule in the morning

Reduced NMN form (NMNH) — higher bioavailability than classic NMN.

Where to buy

Affiliate link — we may earn a commission at no extra cost to you.

Articles on NMN (Nicotinamide Mononucleotide)

All articles